Patrick Hwu, President and CEO at Moffitt Cancer Center, shared a post on LinkedIn:
“New episode of The ImmunoVerse podcast is live!
I had the honor of speaking with James Mule‘, a true pioneer in cell therapy and cancer immunology at Moffitt Cancer Center.
In this episode, he talks about carrying immunotherapy, particularly T cell therapy, from skepticism to standard of care.
Listen now at moffitt.org/immunoverse or on your favorite podcast platform!”
Proceed to the video attached to the post.
More posts featuring ImmunoVerse podcast .